Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Febbo Phillip G.Chief Medical Officer2017-02-16Sell2,49520,644$30.0975.07-1.8620,644 (Direct)
Cole G BradleyCOO2017-02-15Sell5,00039,728$291451.8339,728 (Direct)
Shak StevenChief Scientific Officer2017-01-23Sell5,000327,207$27.28136.48.25327,207 (Direct)
Cole G BradleyCOO2017-01-10Sell5,00035,882$29.22146.11.0635,882 (Direct)
Cole G BradleyCOO2016-12-06Sell5,00035,882$30.61153.05-3.5335,882 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2016-12-05Sell5,000289,594$30.02150.1-1.6359,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.27-6.9314,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.55-6.87327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.4-0.5135,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.442.2559,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.95-2.83327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.59-3.4735,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.04-0.5126,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.1510.06327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.647.7335,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.28.41327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.0227029.29
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.352.2935,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.222.7529,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.17.7327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.210.8535,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8514.59327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.110.9335,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.925.4632,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.61386.9934,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.018.5715,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$28565.4631,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.316.12326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.085.4624,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-8.126,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-6.8227,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-12.1924,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.040.9227,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.190.6812,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.660.6824,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1213.4530,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9816.4930,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.127.2630,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.9612.5430,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.167.2329,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.84-5.59Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-2.9929,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-7.46Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-7.2629,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-1.11Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-5.8721,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-7.526,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-11.75Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-10.49Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-9.1921,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-15.19Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-16.4622,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-18.526,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-4.06Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.082.6422,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-0.97Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-1.8622,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.27.93312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2113.27Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.7711.06Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.229.1722,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$271899.37312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.1110.48312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.313.14Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.486.9224,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.788.2122,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.6211.27Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3617.723,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.7512.5311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$27819.3722,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.524.13311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.286.3822,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.585.9215,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.667.85311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$27819.3724,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-6.28308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-1.57Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.514.8318,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-0.14308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-3.75Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-11.1921,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-15.446,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-14.6Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-11.4821,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-5.918,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-0.47308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-1.57Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-1.418,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-12.45313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-13.93Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-9.2218,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-10.2421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-6.226,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-10.46318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-10.6Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-10.9221,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-10.9221,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-12.2719,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-16.42318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-14.68Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-12.6617,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-12.6617,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-11.413,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-11.9323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-17.24Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-17.717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-19.0313,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-18.34
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-19.56
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-18.876,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-19.95
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-20.04
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-21.217,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-20.6327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-18.98
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-17.586,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-14.01
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-14.217,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-14.9Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-18.0217,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-17.9512,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-1.57Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.486.2612,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.433.3612,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.586.3
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.44.987,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.53.982,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.963.69
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.534.9
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.085.3514,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.542.646,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.55.4617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.75.9214,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.76.45333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.956.26Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$28845.4617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.686.076,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.1210.06288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.79.61338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.269.8236,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.528.09288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.28.41Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.16.18288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$28845.4617,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.553.1814,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-10.73Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-16.23343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-12.6117,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-12.5811,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-15.1414,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-12.53348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-6.82Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-15.6514,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-16.112,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-15.6353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-14.95Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-3.1514,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-17.746,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-13.76358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-15.05Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-16.56Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-17.8614,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-11.19363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-11.48Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-11.48Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-11.96Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-13.0713,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-12.63367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-8.46
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-10.626,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-12.84
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-13.73Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-12.3517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-1.44
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-2.28Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.182.2913,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.693.8
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.424.686,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.655.73372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.956.26Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.985.5418,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.83.29Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-2.4813,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-1.83377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-1.8Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-1.8Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-1.83377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-4.9919,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-4.9Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-1.3713,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-1.93
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-1.93
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-1.93
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-0.94
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-0.94
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-0.94
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.191.62
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.61.62
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.711.62
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.52853.61Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.74.94382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.385.24
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.85.24
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.15.24
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.650.65
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.850.54
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.340.54
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.762.6820,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.712.6820,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.612.8Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.2412.03
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.0912.03
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.1312.03
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.612.8Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.1811.5614,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.027.346,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.111.77Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.110.93Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.710.43382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$28285.4617,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.857.237,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.27.54Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1513.45387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.88.21Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.483.297,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.635.01
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.726.76
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.165.01
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3113.97
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1613.84
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7813.97
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3513.27392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.986.57
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.666.57
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.537.97
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.198.45
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.488.45
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.88.41Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.5210.23
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.511.027,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7413.84
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4913.84
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9420.63
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1633.746,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.835.71392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.629.35Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5532.367,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.241.9Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.233.747,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.128.28392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.820.83Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1516.97,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1516.97,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.911.646,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.056.95392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.27.931,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.76.457,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.68.89392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9113.9718,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.814.951,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1212.75
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9212.75
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6812.71
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4512.87,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.618.01
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.067.97
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.37.97
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7515.58392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.4811.5219,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.210.77Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8313.887,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0813.4Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.916.35Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9215.85Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3216.63Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.213.75Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.559.74Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2520.78Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3221.57Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7924.13Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3221.57Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.415.26Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3813.45Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0817.04Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7817.84Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1217.84Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4416.03Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0614.95Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.714.95Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9226.25Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2126.25Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3526.9Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5131.19Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0831.19Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244433.02Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.239.62Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.239.62Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8740.22Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.635.9Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6533.44Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6830.03Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.231.48Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.630.43Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514068.74Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.163.69Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.461.63Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279111.68Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7895.56Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.498.59Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5396.74Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1599.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9299.39Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.64104.22Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.13104.22Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07105.5Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73105.5Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.81103.37Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.3103.37Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9497Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6197Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5695.95Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4298.86Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7698.86Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.596.87Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.2100.75Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.58102.12Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.23102.12Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.28100.2Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2130.52Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41126.28Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283108.69Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04110.18Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2487.14Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6886.07Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.289.17Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.890.39Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.475.04Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.574.73Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1474.94Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538951.83Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338653.01Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4852.29Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3251.83Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7948.92Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1573.2Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7973.2Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.671.39Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7868.65Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5273.6Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9473.6Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3472.29Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2571.19Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8769.03Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.646.77Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9544.83Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8444.61Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8845.9Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7845.76Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.253.72Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3347.36Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8847.72Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5847.65Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2543Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.144.61Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9242.93Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179839.49Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6539.75Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6542.45Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0442.86Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1446.77Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8542.18Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7447.8Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2747.8Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6847.8Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9147.8Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6551.2Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010047.65Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4451.51Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8851.44Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.851.51Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8851.51Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0452.06Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1751.59Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1184.45
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1184.45
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6261.63
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8966.93
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199555.42
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9164.33
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6264.33
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8164.33
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4564.33
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.646.77
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5251.75
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7251.05
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.151.05
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4651.05
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8251.05
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2849.75
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6415.94
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9716.86
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.852.22
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5554.36
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.637.22
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3643.35
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3643.35
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.241.63
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8552.14
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0246.41
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1153.4
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1153.4
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.860.49
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9848.62
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9848.62
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.647.28
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.746.41
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3245.04
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.431.19
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3530.26
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4835.52
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6528.78
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0330.15
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0824.76
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460621.82
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1224.28
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125240.62
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1553.32
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20247.65
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0448.24
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7748.32
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4648.32
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0548.32
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2864.15
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522557.49
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.253.24
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6471.49
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0856.74
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.844.19
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1545.97
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2230.78
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1228.34
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1928.73
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4815.62
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8930.32
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9327.84
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4134.23
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8428
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4427.23
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9246.48
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8448.84
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.449.9
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2849.97
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5950.89
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3757.41
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9248.32
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9951.9
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1639.42
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018855.34
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9254.12
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2968.17
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8980.94
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8780.94
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.180.94
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0980.94
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7778
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6678
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.978
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6278
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6190.52
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0290.52
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.690.52
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8490.52
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9590.52
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9590.52
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4477.68
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.581.05
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2470.99
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4372.09
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1561.54
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8761.54
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.361.54
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2861.54
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2661.54
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.260.93
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1563.24
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8863.24
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.463.15
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0963.24
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4163.24
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1662.43
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2650.43
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1459.28
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.259.28
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7359.28
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0459.28
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0459.28
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5761.81
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5661.81
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0461.81
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6761.81
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5561.81
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4462.97
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8155.67
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8536.84
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4536.84
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1736.84
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0736.84
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.734.41
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3843.35
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8843.35
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1343.35
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2643.35
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72110.18Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21110.18Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17110.18Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79146.08Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21146.08Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK